121 related articles for article (PubMed ID: 14644341)
1. Implementation of a molecular epidemiology approach to human pleural malignant mesothelioma.
Puntoni R; Filiberti R; Cerrano PG; Neri M; Andreatta R; Bonassi S
Mutat Res; 2003 Nov; 544(2-3):385-96. PubMed ID: 14644341
[TBL] [Abstract][Full Text] [Related]
2. Five years update on relationships between malignant pleural mesothelioma and exposure to asbestos and other elongated mineral particles.
Andujar P; Lacourt A; Brochard P; Pairon JC; Jaurand MC; Jean D
J Toxicol Environ Health B Crit Rev; 2016; 19(5-6):151-172. PubMed ID: 27705546
[TBL] [Abstract][Full Text] [Related]
3. Pleural mesothelioma and lung cancer: the role of asbestos exposure and genetic variants in selected iron metabolism and inflammation genes.
Celsi F; Crovella S; Moura RR; Schneider M; Vita F; Finotto L; Zabucchi G; Zacchi P; Borelli V
J Toxicol Environ Health A; 2019; 82(20):1088-1102. PubMed ID: 31755376
[TBL] [Abstract][Full Text] [Related]
4. Differential mutation profiles and similar intronic TP53 polymorphisms in asbestos-related lung cancer and pleural mesothelioma.
Andujar P; Pairon JC; Renier A; Descatha A; Hysi I; Abd-Alsamad I; Billon-Galland MA; Blons H; Clin B; Danel C; Debrosse D; Galateau-Sallé F; Housset B; Laurent-Puig P; Le Pimpec-Barthes F; Letourneux M; Monnet I; Régnard JF; Validire P; Zucman-Rossi J; Jaurand MC; Jean D
Mutagenesis; 2013 May; 28(3):323-31. PubMed ID: 23435014
[TBL] [Abstract][Full Text] [Related]
5. Metabolic genotypes as modulators of asbestos-related pleural malignant mesothelioma risk: a comparison of Finnish and Italian populations.
Neri M; Taioli E; Filiberti R; Paolo Ivaldi G; Aldo Canessa P; Verna A; Marroni P; Puntoni R; Hirvonen A; Garte S
Int J Hyg Environ Health; 2006 Jul; 209(4):393-8. PubMed ID: 16697254
[TBL] [Abstract][Full Text] [Related]
6. Gene-asbestos interaction in malignant pleural mesothelioma susceptibility.
Tunesi S; Ferrante D; Mirabelli D; Andorno S; Betti M; Fiorito G; Guarrera S; Casalone E; Neri M; Ugolini D; Bonassi S; Matullo G; Dianzani I; Magnani C
Carcinogenesis; 2015 Oct; 36(10):1129-35. PubMed ID: 26139392
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2, epidermal growth factor receptor, and aromatase signaling in inflammation and mesothelioma.
Nuvoli B; Galati R
Mol Cancer Ther; 2013 Jun; 12(6):844-52. PubMed ID: 23729401
[TBL] [Abstract][Full Text] [Related]
8. Comparative proteomic analysis of malignant pleural mesothelioma evidences an altered expression of nuclear lamin and filament-related proteins.
Giusti L; Da Valle Y; Bonotti A; Donadio E; Ciregia F; Ventroni T; Foddis R; Giannaccini G; Guglielmi G; Cristaudo A; Lucacchini A
Proteomics Clin Appl; 2014 Apr; 8(3-4):258-68. PubMed ID: 24415579
[TBL] [Abstract][Full Text] [Related]
9. Biological agents involved in malignant mesothelioma: relevance as biomarkers or therapeutic targets.
Crispi S; Cardillo I; Spugnini EP; Citro G; Menegozzo S; Baldi A
Curr Cancer Drug Targets; 2010 Feb; 10(1):19-26. PubMed ID: 20088796
[TBL] [Abstract][Full Text] [Related]
10. Asbestos fibers contributing to the induction of human malignant mesothelioma.
Suzuki Y; Yuen SR
Ann N Y Acad Sci; 2002 Dec; 982():160-76. PubMed ID: 12562635
[TBL] [Abstract][Full Text] [Related]
11. The risk of lung cancer after cessation of asbestos exposure in construction workers using pleural malignant mesothelioma as a marker of exposure.
Järvholm B; Aström E
J Occup Environ Med; 2014 Dec; 56(12):1297-301. PubMed ID: 25479300
[TBL] [Abstract][Full Text] [Related]
12. Microstructures and biological influence of environmental exposure of asbestos.
Yada K; Kohyama N
Biomed Mater Eng; 2009; 19(2-3):231-9. PubMed ID: 19581718
[TBL] [Abstract][Full Text] [Related]
13. Global use of asbestos and the incidence of mesothelioma.
Tossavainen A
Int J Occup Environ Health; 2004; 10(1):22-5. PubMed ID: 15070022
[TBL] [Abstract][Full Text] [Related]
14. Pleural mesothelioma in Poland: Spatial analysis of malignant mesothelioma prevalence in the period 1999-2013.
Krówczyńska M; Wilk E; Pabjanek P; Olędzka G
Geospat Health; 2018 Nov; 13(2):. PubMed ID: 30451473
[TBL] [Abstract][Full Text] [Related]
15. Descriptive epidemiology of malignant mesothelioma.
Bertazzi PA
Med Lav; 2005; 96(4):287-303. PubMed ID: 16457426
[TBL] [Abstract][Full Text] [Related]
16. [Asbestos and malignant pleural mesothelioma: molecular, cellular and physiopathological aspects].
Mohr S; Keith G; Rihn B
Bull Cancer; 2005 Nov; 92(11):959-76. PubMed ID: 16316830
[TBL] [Abstract][Full Text] [Related]
17. Malignant and non-malignant asbestos-related pleural and lung disease: 10-year follow-up study.
Cvitanović S; Znaor L; Konsa T; Ivancević Z; Perić I; Erceg M; Vujović M; Vuković J; Beg-Zec Z
Croat Med J; 2003 Oct; 44(5):618-25. PubMed ID: 14515425
[TBL] [Abstract][Full Text] [Related]
18. A molecular epidemiology case control study on pleural malignant mesothelioma.
Bolognesi C; Martini F; Tognon M; Filiberti R; Neri M; Perrone E; Landini E; Canessa PA; Ivaldi GP; Betta P; Mutti L; Puntoni R
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1741-6. PubMed ID: 16030111
[TBL] [Abstract][Full Text] [Related]
19. Effects on health of non-occupational exposure to airborne mineral fibres.
Gardner MJ; Saracci R
IARC Sci Publ; 1989; (90):375-97. PubMed ID: 2663717
[TBL] [Abstract][Full Text] [Related]
20. The CREST biorepository: a tool for molecular epidemiology and translational studies on malignant mesothelioma, lung cancer, and other respiratory tract diseases.
Ugolini D; Neri M; Canessa PA; Casilli C; Catrambone G; Ivaldi GP; Lando C; Marroni P; Paganuzzi M; Parodi B; Visconti P; Puntoni R; Bonassi S
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3013-9. PubMed ID: 18990743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
